Identifying Potential Therapeutics for Osteoporosis by Exploiting the Relationship between Mevalonate Pathway and Bone Metabolism.
CONCLUSION: mevalonate pathway can be exploited to develop effective antiosteoporosis agents.
PMID: 29683099 [PubMed - as supplied by publisher]
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Endocr Metab Immune Disord Drug Targets Source Type: research
More News: Annatto | Cholesterol | Drugs & Pharmacology | Orthopaedics | Osteoporosis | Statin Therapy | Study | Vitamin E | Vitamins